Maintenance of hemostasis during exodontia in two hemophiliacs with factor VIII inhibitors.
This paper reviews hemophilia A with emphasis on the 10% of afflicted patients who have inhibitors to factor VIII. Two patients with the latter problem are presented, and a management program is described and illustrated.
D000293:Adolescent; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D000906:Antibodies / Q000032:analysis; D001779:Blood Coagulation Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D003730:Dental Care for Persons with Disabilities / Q000379:methods; D005169:Factor VIII / Q000276:immunology; D006467:Hemophilia A / Q000276:immunology / Q000503:physiopathology*; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D014081:Tooth Extraction
D000614:Aminocaproates; D000906:Antibodies; D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005169:Factor VIII; D015119:Aminocaproic Acid